Brca2^{(p.T1942fs/+)} dissipates ovarian reserve in rats through oxidative stress in follicular granulosa cells

References

• Armstrong K, Weiner J, Weber B, et al. Early adoption of BRCA1/2 testing: who and why. Genet Med. 2003;5(2):92–98. doi:10.1097/01.GIM.0000056829.76915.2A.
   PubMed Web of Science ®Google Scholar
• Momozawa Y, Sasai R, Usui Y, et al. Expansion of cancer risk profile for BRCA1 and BRCA2 pathogenic variants. JAMA Oncol. 2022;8(6):871–878. doi:10.1001/jamaoncol.2022.0476.
   PubMed Web of Science ®Google Scholar
• Oktay K, Kim JY, Barad D, et al. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol. 2010;28(2):240–244. doi:10.1200/JCO.2009.24.2057.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski F, Arbre M, Bidet Y, et al. BRCA mutations increase fertility in families at hereditary breast/ovarian cancer risk. PLoS One. 2015;10(6):e0127363. doi:10.1371/journal.pone.0127363.
   PubMed Web of Science ®Google Scholar
• Smith KR, Hanson HA, Mineau GP, et al. Effects of BRCA1 and BRCA2 mutations on female fertility. Proc Biol Sci. 2012;279(1732):1389–1395. doi:10.1098/rspb.2011.1697.
   PubMed Web of Science ®Google Scholar
• Scully R, Livingston DM. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature. 2000;408(6811):429–432. doi:10.1038/35044000.
   PubMed Web of Science ®Google Scholar
• de la Hoya M, Fernandez JM, Tosar A, et al. Association between BRCA1 mutations and ratio of female to male births in offspring of families with breast cancer, ovarian cancer, or both. JAMA. 2003;290(7):929–931. doi:10.1001/jama.290.7.929.
   PubMed Web of Science ®Google Scholar
• Ballal RD, Saha T, Fan S, et al. BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage. J Biol Chem. 2009;284(52):36083–36098. doi:10.1074/jbc.M109.025825.
   PubMed Web of Science ®Google Scholar
• French JD, Dunn J, Smart CE, et al. Disruption of BRCA1 function results in telomere lengthening and increased anaphase bridge formation in immortalized cell lines. Genes Chromosomes Cancer. 2006;45(3):277–289. doi:10.1002/gcc.20290.
   PubMed Web of Science ®Google Scholar
• McPherson JP, Hande MP, Poonepalli A, et al. A role for Brca1 in chromosome end maintenance. Hum Mol Genet. 2006;15(6):831–838. doi:10.1093/hmg/ddl002.
   PubMed Web of Science ®Google Scholar
• Winship AL, Griffiths M, Lliberos Requesens C, et al. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation. Hum Reprod. 2020;35(8):1864–1874. doi:10.1093/humrep/deaa128.
   PubMed Web of Science ®Google Scholar
• Finch A, Valentini A, Greenblatt E, et al. Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation. Fertil Steril. 2013;99(6):1724–1728. doi:10.1016/j.fertnstert.2013.01.109.
   PubMed Web of Science ®Google Scholar
• Giordano S, Garrett-Mayer E, Mittal N, et al. Association of BRCA1 mutations with impaired ovarian reserve: connection between infertility and breast/ovarian cancer risk. J Adolesc Young Adult Oncol. 2016;5(4):337–343. doi:10.1089/jayao.2016.0009.
   PubMed Web of Science ®Google Scholar
• Lin WT, Beattie M, Chen LM, et al. Comparison of age at natural menopause in BRCA1/2 mutation carriers with a non-clinic-based sample of women in Northern California. Cancer. 2013;119(9):1652–1659. doi:10.1002/cncr.27952.
   PubMed Web of Science ®Google Scholar
• Johnson L, Sammel MD, Domchek S, et al. Antimullerian hormone levels are lower in BRCA2 mutation carriers. Fertil Steril. 2017;107(5):1256–1265.e6. doi:10.1016/j.fertnstert.2017.03.018.
   PubMed Web of Science ®Google Scholar
• Rzepka-Górska I, Tarnowski B, Chudecka-Głaz A, et al. Premature menopause in patients with BRCA1 gene mutation. Breast Cancer Res Treat. 2006;100(1):59–63. doi:10.1007/s10549-006-9220-1.
   PubMed Web of Science ®Google Scholar
• Lambertini M, Goldrat O, Ferreira AR, et al. Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients. Ann Oncol. 2018;29(1):237–243. doi:10.1093/annonc/mdx639.
   PubMed Web of Science ®Google Scholar
• Ma Y, Vassetzky Y, Dokudovskaya S. mTORC1 pathway in DNA damage response. Biochim Biophys Acta Mol Cell Res. 2018;1865(9):1293–1311. doi:10.1016/j.bbamcr.2018.06.011.
   PubMed Web of Science ®Google Scholar
• Maidarti M, Anderson RA, Telfer EE. Crosstalk between PTEN/PI3K/akt signalling and DNA damage in the oocyte: implications for primordial follicle activation, oocyte quality and ageing. Cells. 2020;9(1):200. doi:10.3390/cells9010200.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick SL, Richards JS. Identification of a cyclic adenosine 3’,5’-monophosphate-response element in the rat aromatase promoter that is required for transcriptional activation in rat granulosa cells and R2C leydig cells. Mol Endocrinol. 1994;8(10):1309–1319. doi:10.1210/mend.8.10.7854348.
   PubMedGoogle Scholar
• Noma N, Kawashima I, Fan HY, et al. LH-induced neuregulin 1 (NRG1) type III transcripts control granulosa cell differentiation and oocyte maturation. Mol Endocrinol. 2011;25(1):104–116. doi:10.1210/me.2010-0225.
   PubMedGoogle Scholar
• Evers B, Jonkers J. Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects. Oncogene. 2006;25(43):5885–5897. doi:10.1038/sj.onc.1209871.
   PubMed Web of Science ®Google Scholar
• Cora MC, Kooistra L, Travlos G. Vaginal cytology of the laboratory rat and mouse: review and criteria for the staging of the estrous cycle using stained vaginal smears. Toxicol Pathol. 2015;43(6):776–793. doi:10.1177/0192623315570339.
   PubMed Web of Science ®Google Scholar
• Myers M, Britt KL, Wreford NG, et al. Methods for quantifying follicular numbers within the mouse ovary. Reproduction. 2004;127(5):569–580. doi:10.1530/rep.1.00095.
   PubMed Web of Science ®Google Scholar
• Bilotas MA, Olivares CN, Ricci AG, et al. Interplay ­between endometriosis and pregnancy in a mouse model. PLoS One. 2015;10(4):e0124900. doi:10.1371/journal.pone.0124900.
   PubMed Web of Science ®Google Scholar
• Kalich-Philosoph L, Roness H, Carmely A, et al. Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility. Sci Transl Med. 2013;5(185):185ra62. doi:10.1126/scitranslmed.3005402.
   PubMed Web of Science ®Google Scholar
• Te Velde ER, Scheffer GJ, Dorland M, et al. Developmental and endocrine aspects of normal ovarian aging. Mol Cell Endocrinol. 1998;145(1–2):67–73. doi:10.1016/s0303-7207(98)00171-3.
   PubMed Web of Science ®Google Scholar
• de Vet A, Laven JS, de Jong FH, et al. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77(2):357–362. doi:10.1016/s0015-0282(01)02993-4.
   PubMed Web of Science ®Google Scholar
• Takeuchi A, Koga K, Satake E, et al. Endometriosis triggers excessive activation of primordial follicles via PI3K-PTEN-Akt-Foxo3 pathway. J Clin Endocrinol Metab. 2019;104(11):5547–5554. doi:10.1210/jc.2019-00281.
   PubMed Web of Science ®Google Scholar
• Ma J, Cai H, Wu T, et al. PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function. Mol Cell Biol. 2012;32(8):1506–1517. doi:10.1128/MCB.06271-11.
   PubMed Web of Science ®Google Scholar
• Toyokuni S. The origin and future of oxidative stress pathology: from the recognition of carcinogenesis as an iron addiction with ferroptosis resistance to non-thermal plasma therapy. Pathol Int. 2016;66(5):245–259. doi:10.1111/pin.12396.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Mori T, Dizdaroglu M. DNA base modifications in renal chromatin of wistar rats treated with a renal carcinogen, ferric nitrilotriacetate. Int J Cancer. 1994;57(1):123–128. doi:10.1002/ijc.2910570122.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Luo XP, Tanaka T, et al. Induction of a wide range of C2-12 aldehydes and C7-12 acyloins in the kidney of wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Free Radic Biol Med. 1997;22(6):1019–1027. doi:10.1016/s0891-5849(96)00489-3.
   PubMed Web of Science ®Google Scholar
• Ito F, Yanatori I, Maeda Y, et al. Asbestos conceives Fe(II)-dependent mutagenic stromal milieu through ceaseless macrophage ferroptosis and beta-catenin induction in mesothelium. Redox Biol. 2020;36:101616. doi:10.1016/j.redox.2020.101616.
   PubMed Web of Science ®Google Scholar
• Li LT, Jiang G, Chen Q, et al. Ki67 is a promising molecular target in the diagnosis of cancer. Mol Med Rep. 2015;11(3):1566–1572. doi:10.3892/mmr.2014.2914.
   PubMed Web of Science ®Google Scholar
• Gonfloni S, Jodice C, Gustavino B, et al. DNA damage stress response and follicle activation: signaling routes of mammalian ovarian reserve. Int J Mol Sci. 2022;23(22):14379. doi:10.3390/ijms232214379.
   PubMed Web of Science ®Google Scholar
• Bellusci G, Mattiello L, Iannizzotto V, et al. Kinase-independent inhibition of cyclophosphamide-induced pathways protects the ovarian reserve and prolongs fertility. Cell Death Dis. 2019;10(10):726. doi:10.1038/s41419-019-1961-y.
   PubMedGoogle Scholar
• Zhang X, Zhang W, Wang Z, et al. Enhanced glycolysis in granulosa cells promotes the activation of primordial follicles through mTOR signaling. Cell Death Dis. 2022;13(1):87. doi:10.1038/s41419-022-04541-1.
   PubMed Web of Science ®Google Scholar
• Kitajima M, Dolmans MM, Donnez O, et al. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas. Fertil Steril. 2014;101(4):1031–1037. doi:10.1016/j.fertnstert.2013.12.049.
   PubMed Web of Science ®Google Scholar
• Hayashi S, Nakamura T, Motooka Y, et al. Novel ovarian endometriosis model causes infertility via iron-mediated oxidative stress in mice. Redox Biol. 2020;37:101726. doi:10.1016/j.redox.2020.101726.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Tanaka T, Hattori Y, et al. Quantitative immunohistochemical determination of 8-hydroxy-2’-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest. 1997;76:365–374.
   PubMed Web of Science ®Google Scholar
• Zheng H, Jiang L, Tsuduki T, et al. Embryonal erythropoiesis and aging exploit ferroptosis. Redox Biol. 2021;48:102175. doi:10.1016/j.redox.2021.102175.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Miyake N, Hiai H, et al. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett. 1995;359(2–3):189–191. doi:10.1016/0014-5793(95)00033-6.
   PubMed Web of Science ®Google Scholar